ABCDEFGHIJKLMNOPQRSTUVWXYZ
1
Sheet nameDescriptionNotes
2
PRV issuances by diseaseOverview of products awarded priority review vouchers under the Tropical Disease Priority Review Voucher (TD PRV) Program (2009-2023), organized by diseaseSupplements drugdatabase.info source with four additional drugs (moxidectin, Ervebo, fexinidazole, and Lampit) per the Ridley website.
3
Approvals by drug awarded PRVsProducts awarded priority review vouchers under TD PRV (2009-2023) – information about their approval by FDA and WHO PQ/EML; organized by product
4
Drug extents of use and use ratesProducts awarded priority review vouchers under TD PRV (2009-2023) – information about their extent of use; specifically, we calculate treatment courses per 1,000 incidence, or "use rate"; qualitative indicators of use extent also included; organized by product
5
PRV sales and value distribution by sponsorPriority review vouchers granted under TD PRV (2009-2023); includes details of sale, subsequent voucher redemption, and value distribution; organized by drug sponsorTo contextualize revenue size, top ~20 pharmaceutical corporations that have not received or purchased PRVs are included as hidden rows.
6
Hidden - Drug database (2009-2021)A database of the drugs awarded priority review vouchers (2009-2021)Downloaded from drugdatabase.info. Product indications supplied by Rethink Priorities.
7
Hidden - All PRV issuancesA comparison of Citeline's and David Ridley's respective resources that catalog all the products for which PRVs have been issued.Conclude that Citeline's resource is not useful/reliable because it is a subset of Ridley's; its only addition (Nedosiran) is in error.
8
Hidden - Age pyramid for LMICsAge distribution for all "less developed regions."Data from UN Population Division.
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100